Kneat builds enterprise validation software for pharmaceutical and medical device manufacturers operating under strict regulatory frameworks (21 CFR Part 11, EudraLex Annex 11). The tech stack—C#/.NET, React, AWS, Kubernetes, Docker—reflects a mature SaaS backend designed for compliance-grade reliability and scale. Current hiring (9 roles in 30 days, accelerating) skews engineering-heavy with senior-level emphasis, while projects signal two growth vectors: AI-powered document automation and land-expand motion via ABM and strategic account planning.
Kneat is a public company (founded 2006, headquartered in Limerick, Ireland) serving the regulated life sciences sector with software that eliminates paper from validation, commissioning, and qualification workflows. The platform manages the full lifecycle of validation data—creation, storage, access, audit trails—in a format compliant with pharmaceutical and medical device regulations. Customers range from mid-market biotech to large pharma operations. Revenue scaling is driven by land-and-expand plays within existing customer bases alongside new customer acquisition in Europe and internationally.
Core stack: C#, .NET, React, Node.js, AWS (Lambda, Redshift, OpenSearch, Auto Scaling, VPC). Infrastructure: Kubernetes, Docker, NGINX, IIS. Testing: Selenium, SpecFlow. Observability and marketing: PostHog, HubSpot, Salesforce, 6sense.
Next-generation SaaS platform, AI-powered product enhancements (including intelligent autonomous agents for document validation), land-expand sales within existing customers, and ABM campaigns via 6sense targeting strategic accounts.
Kneat Solutions's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.